Divi’s Laboratories reports 24% jump in Q4 consolidated net profit

14 May 2012 Evaluate

Drug firm Divi’s Laboratories’ consolidated net profit rose by 23.81% to Rs 216.91 crore for the fourth quarter ended December 31, 2012, on account of robust sales during the quarter. The company had posted a net profit of Rs 175.19 crore during the same period of previous fiscal.

The company’s net sales rose by 47.50% to Rs 722.53 crore for the fourth quarter, as compared to Rs 489.82 crore during the same period previous financial year.

For the year ended March 31, 2012, the company reported a jump of 24.23% in its net profit of Rs 533.26 crore as against Rs 429.27 crore during 2010-11.

The company’s net sales for the year ended March 31, 2012 rose to Rs 1920.01 crore, compared to Rs 1343.66 crore during 2010-11, up by 42.89%.

The company’s board recommended a dividend of Rs 13 per share of Rs 2 each for the year ended March 31, 2012.

Divis Lab Share Price

6473.35 2.75 (0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×